AnalystBook Research · Company Intelligence

COTY INC.

COTYNYSE

Built from COTY INC.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Coty's sales, earnings, and FCF declined, but insider purchases were active.

The read at a glance✓ Audited against SEC data
  • Business mixPrestige and Consumer BeautyNote
  • Revenue$5.89B, -3.7%Watch
  • Net income($0.37B)Watch
  • FCF$0.28B, -24.9%Watch
  • Insiders7 purchases / 0 salesOK
  • Altman/Beneish/EQDistress Z; clean M/EQWatch
  • Debt$3.96B, +3.0%Watch

Business

Coty is a beauty company with Prestige and Consumer Beauty segments.

Where the revenue comes from

Fiscal 2026, as COTY INC. reports it. History and quarterly detail are in the app.

  • Prestige$3.8B
  • Consumer Beauty$2.0B

Leadership changes

From COTY INC.'s own filings, the day they're filed.

  • Priya Srinivasan · Chief People and Purpose Officer of Coty Inc · departureeff. 2026-08-31
  • Isabelle Parize · Directors · departureeff. 2026-06-30
  • Beatrice Ballini · Directors · departureeff. 2026-06-30

Latest filings

  • 8-K · Company announcement2026-08-20
  • 10-K · Annual report2026-08-20
  • 8-K · Company announcement2026-08-19
  • 8-K · Company announcement2026-07-07
  • 8-K · Company announcement2026-07-02
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about COTY INC., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.